“…[13][14][15] However, there are concerns regarding lack of confidentiality and stigma, [16][17][18][19] as well as sustained benefits of DOT after release from correctional facilities, when patients must transition to self-administra-tion of medications. Data show that the proportion of those who continue ARVs immediately after release is low, 16,[20][21][22][23][24] which is particularly important, as the postrelease period is a time of high-risk behaviors.…”